How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

630 results for

Dyspepsia in Pregnancy

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

161. Gastroesophageal Reflux Disease (GERD)

Symptomatology 7 2.3 Natural history 9 2.4 Alarm features 9 3 Diagnosis 10 3.1 Diagnostic considerations 10 3.2 Patient history and physical examination 13 3.3 Diagnostic tests for GERD 15 3.4 Differential diagnosis 17 3.5 Cascades for the diagnosis of GERD 18 4 Management 19 4.1 Management principles 19 4.2 Stepwise therapy 19 4.3 GERD treatment in pregnancy 23 4.4 Surgical interventions 24 4.5 Managing complications of GERD 24 4.6 Cascades for the management of GERD 25 5 Appendix 27 5.1 Abbreviations (...) and definitions 27 5.2 Gold standard guidelines on GERD 28 5.3 Los Angeles classification of erosive esophagitis 29 5.4 Prague criteria for Barrett’s esophagus 29 5.5 Regional epidemiologic data on GERD 29 6 References 33 Tables Table 1 GERD symptoms: range of incidence 6 Table 2 The Montreal definition of GERD 7 Table 3 GERD symptoms 8 Table 4 Diagnostic options for GERD 16 Table 5 Cascades for the diagnosis of GERD 18 Table 6 Treatment options for GERD in pregnancy 23 Table 7 Recommendations

2015 World Gastroenterology Organisation

162. Acute Pain Management: Scientific Evidence

and Faculty of Pain Medicine (2015), Acute Pain Management: Scientific Evidence (4th edition), ANZCA & FPM, Melbourne. Copyright information for Tables 10.1 and 10.2 The material presented in Table 10.1 and Table 10.2 of this document has been reproduced with permission from Prescribing Medicines in Pregnancy, 2015, Therapeutic Goods Administration. It does not purport to be the official or authorised version. © Commonwealth of Australia 2015 This work is copyright. You may download, display, print (...) Nonpharmacological therapies 484 References 485 10. OTHER SPECIFIC PATIENT GROUPS 515 10.1 The pregnant patient 515 10.1.1 Management of acute pain during pregnancy 515 10.1.2 Pain syndromes in pregnancy 517 10.1.3 Management of acute pain during labour and birth 522 10.1.4 Pain management during lactation 533 10.1.5 Pain in the puerperium 538 10.2 The older patient 540 10.2.1 Physiology and perception of pain 540 10.2.2 Assessment of pain 542 10.2.3 Pharmacokinetic and pharmacodynamic changes 544 10.2.4 Drugs

2015 Clinical Practice Guidelines Portal

163. Salazopyrine (A07EC01 (intestinal anti-inflammatory agents)) - Ulcerative colitis, Crohn's disease in the colon, Rheumatoid arthritis

product can be used during pregnancy at the lowest possible effective dose. Sulfasalazine is one of the DMARDs recommended by the American College of Rheumatology (2012 recommendations). 05 TRANSPARENCY COMMITTEE CONCLUSIONS In view of all the above information, and following the debate and vote, the Committee considers that the conclusions in its previous opinion on 24 October 2007 have changed as follows: 05.1 Actual benefit: Disease-modifying treatment for rheumatoid arthritis Rheumatoid (...) disorders Peripheral neuropathy, aseptic meningitis, encephalopathy. Taste and smell disorders. Ear and labyrinth disorders Tinnitus, vertigo Cardiac disorders Rare: pericarditis. Respiratory, thoracic and mediastinal disorders Rare: fibrosing alveolitis, eosinophilic interstitial lung disease. Dyspnoea, cough. Gastrointestinal disorders Abdominal pains, nausea, dyspepsia. Very rare: pseudomembranous colitis. Hepatobiliary disorders Elevated liver enzymes, hepatitis (exceptionally fulminant hepatitis

2015 Haute Autorite de sante

175. Neuro-urology

/stillbirths with/without pregnancy termination [40]. Lumbar and lumbosacral form are the most common (60%). Urethrovesical dysfunction in myelomeningocele is very high (90-97%). 50% of these children demonstrate DO. Low compliance is also frequent (alone/associated with can develop with time). Urethral behaviour varies from dyssynergia (50%), normal reflexes (25%) and denervation (25%) [41]. Lesions and diseases of the peripheral nervous system Lumbar spine Degenerative disease Disk prolapse Lumbar canal

2015 European Association of Urology

178. Improving the Reporting of Clinical Trials of Infertility Treatments (IMPRINT): modifying the CONSORT statement

and during pregnancy and the puerperium, which creates a unique burden of follow-up for clinical trial investi- gators and participants. In 2013, because of the inconsistencies in trial reporting and the unique aspects of infertility trials not adequatelyaddressedbyexistingConsolidatedStandardsofReportingTrials(CONSORT)statements,weconvenedaconsensusconfer- enceinHarbin,China,withtheaimofplanningmodi?cationstotheCONSORTchecklisttoimprovethequalityofreportingofclinical trials testing infertility treatment (...) / OCTOBER 2014 ASRM PAGEScontributestoincompletereportingofoutcomesandharmsof treatment.Clinicaltrialsininfertilityfrequentlydonotreport items of critical importance regarding ef?cacy, such as ongoing pregnancy (3, 4) or live birth of a healthy infant, arguably the most important event (5). Rather, they often focus on surrogate outcomes of varying clinical importance, suchas ovulation rates,number of oocytes retrieved embryo, and fertilization and implantation rates (6, 7). Reports on the safety

2014 Society for Assisted Reproductive Technology

180. Pharmacologic Therapy for Pulmonary Arterial Hypertension in Adults

) and to delay the time to clinical worsening (Grade CB) . 74. For WHO FC III or IV P AH patients with unac- ceptable or deteriorating clinical status despite established P AH-specifi c therapy with two classes of P AH pharmacotherapy, we suggest addition of a third class of P AH therapy (Grade CB) . Remark: Such patients are ideally evaluated at centers with expertise in the evaluation and treatment of co m p lex pa tien ts wi t h P AH. S p ecifi c Patient Situations Pregnancy 75. In patients with P AH, we (...) suggest that pregnancy be avoided (Grade CB) . Remark: Estrogen-containing contraceptives may increase the risk of VTE and are not recommended for women with childbearing potential who have PAH. Additionally, the ETRA bosentan may decrease the effi cacy of hormonal contraception. Bosentan, ambrisentan, macitentan and riociguat are contraindicated in pregnancy (category X; evidence of serious fetal abnormalities) and dual mechanical barrier contracep- tive techniques are recommended in female patients

2014 American College of Chest Physicians

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>